Molecular Weight:464.825 g/mol
Product description:Sorafenib tosylate is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advancedrenal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: firstname.lastname@example.org
2. Tel: +86 592 536 5868
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: